NCT06845020View on ClinicalTrials.gov

CSF Proteomic Characterization of Glioblastomas

Not yet recruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

March 30, 2028

Conditions
GlioblastomaGlioblastoma WHO Grade IVGlioblastoma (GBM)Glioblastoma Multiforme of the BrainGlioblastoma, Adult
Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Hospital Valentin Gomez Farias

OTHER

lead

Univeridad Autonoma de Guadalajara

OTHER

NCT06845020 - CSF Proteomic Characterization of Glioblastomas | Biotech Hunter | Biotech Hunter